HealthAssure
HealthAssureGood Life
ICD10BillableValid for clinical use

ICD-10 Code U07.1: COVID-19

U07.1 is a billable ICD-10 diagnosis code used to classify COVID-19 in medical records and claims. You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records. ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Codes for special purposes (U00-U85).

Reviewed by HealthAssure Clinical TeamUpdated 26 May 2026

What is this code?

ICD-10 codes are diagnosis classification codes used in healthcare records, reporting, coding workflows, and billing support. This code sits within the broader ICD-10 area for Codes for special purposes (U00-U85).

When is it used?

  • May be used when a clinician documents covid-19 in a patient's medical record.
  • May appear in hospital records, claims, referrals, and clinical documentation.
  • This code can be used as a clinically usable diagnosis entry in standardized coding workflows.

What it does not mean

  • A code alone does not explain severity, treatment plan, or outcome.
  • A medical code should not be treated as a substitute for a doctor's diagnosis or advice.

Code hierarchy

chapter
22Codes for special purposes (U00-U85)
block
U00-U49Provisional assignment of new diseases of uncertain etiology or emergency use
category
U07Emergency use of U07
currentU07

Official coding notes

Applicable to
  • code to identify pneumonia or other manifestations, such as:
  • pneumonia due to COVID-19 (J12.82)
  • code, if applicable, for associated conditions such as:
  • COVID-19 associated coagulopathy (D68.8)
  • disseminated intravascular coagulation (D65)
  • hypercoagulable states (D68.69)
  • thrombophilia (D68.69)
Excludes2 (may code together if documented)
  • coronavirus as the cause of diseases classified elsewhere (B97.2-)
  • pneumonia due to SARS-associated coronavirus (J12.81)
Use additional code
  • code to identify pneumonia or other manifestations, such as:
  • pneumonia due to COVID-19 (J12.82)
  • code, if applicable, for associated conditions such as:
  • COVID-19 associated coagulopathy (D68.8)
  • disseminated intravascular coagulation (D65)
  • hypercoagulable states (D68.69)
  • thrombophilia (D68.69)

Where you may see this code

You may see this code in hospital records, discharge summaries, insurance claims, encounter documentation, referrals, or other healthcare billing and coding records.

Related specialists

General Physician

Coverage-related procedures and services

CPT 87631high
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); RESPIRATORY VIRUS (EG, ADENOVIRUS, INFLUENZA VIRUS, CORONAVIRUS, METAPNEUMOVIRUS, PARAINFLUENZA VIRUS, RESPIRATORY SYNCYTIAL VIRUS, RHINOVIRUS), INCLUDES MULTIPLEX REVERSE TRANSCRIPTION, WHEN PERFORMED, AND MULTIPLEX AMPLIFIED PROBE TECHNIQUE, MULTIPLE TYPES OR SUBTYPES, 3-5 TARGETS
Source: CMS coverage guidance
CPT 87636high
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) AND INFLUENZA VIRUS TYPES A AND B, MULTIPLEX AMPLIFIED PROBE TECHNIQUE
Source: CMS coverage guidance
CPT 87637high
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]), INFLUENZA VIRUS TYPES A AND B, AND RESPIRATORY SYNCYTIAL VIRUS, MULTIPLEX AMPLIFIED PROBE TECHNIQUE
Source: CMS coverage guidance
CPT 87801high
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA), MULTIPLE ORGANISMS; AMPLIFIED PROBE(S) TECHNIQUE
Source: CMS coverage guidance
CPT 87428high
INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOASSAY TECHNIQUE (EG, ENZYME IMMUNOASSAY [EIA], ENZYME-LINKED IMMUNOSORBENT ASSAY [ELISA], FLUORESCENCE IMMUNOASSAY [FIA], IMMUNOCHEMILUMINOMETRIC ASSAY [IMCA]), QUALITATIVE OR SEMIQUANTITATIVE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (EG, SARS-COV, SARS-COV-2 [COVID-19]) AND INFLUENZA VIRUS TYPES A AND B
Source: CMS coverage guidance
CPT 87812high
INFECTIOUS AGENT ANTIGEN DETECTION BY IMMUNOASSAY WITH DIRECT OPTICAL (IE, VISUAL) OBSERVATION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]) AND INFLUENZA VIRUS TYPES A AND B
Source: CMS coverage guidance

Coding guidelines

Compatibility

Legacy and official ICD code match exactly.
Legacy codes
U07.1

Common synonyms

COVID-19

Frequently asked questions

Code details

CodeU07.1
SystemICD10
Display nameCOVID-19
ChapterCodes for special purposes (U00-U85)
BlockProvisional assignment of new diseases of uncertain etiology or emergency use

Flags

BillableYes
Valid clinical useYes

Source

SourceICD-10
Version2026-annual
Releaseannual
Year2026

Index terms

Matched terms
COVID-19Coronavirus(infection)Coronavirus(infection)Coronavirus(infection)Disease, diseasedInfection, infected, infective(opportunistic)Infection, infected, infective(opportunistic)Infection, infected, infective(opportunistic)Syndrome
See also
COVID-19

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from ICD-10. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

ICD-10 Code U07.1 for COVID-19 | HealthAssure